Simultaneous wavefront-guided photorefractive keratectomy and corneal collagen crosslinking after intrastromal corneal ring segment implantation for keratoconus

详细信息    查看全文

• 作者：Israel Kremer ; Isaac Aizenman ; Henia Lichter ; Sagit Shayer ; Samuel Levinger
• 刊名：Journal of Cataract and Refractive Surgery
• 出版年：2012
• 出版时间：October, 2012
• 年：2012
• 卷：38
• 期：10
• 页码：1802-1807
• 全文大小：192 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferencesversion=""1.0"" encoding=""UTF-8""?>

Purpose

To study the results of simultaneous photorefractive keratectomy (PRK) and corneal collagen crosslinking (CXL) in keratoconus after previous intrastromal corneal ring segment (ICRS) implantation.

Setting

Enaim Laser Center, Jerusalem, Israel.

Design

Case series.

Methods

This study comprised patients with moderate keratoconus who had previous Intacs ICRS implantation with the Intralase laser at least 6 months before PRK-CXL. Wavefront-guided PRK and ultraviolet-A CXL were performed simultaneously. Refraction, uncorrected (UDVA) and corrected (CDVA) distance visual acuities, keratometry (K) values, endothelial cell count (ECC), pachymetry, corneal resistance factor (CRF), and corneal hysteresis (CH) were assessed 3, 6, and 12 months postoperatively.

Results

Twelve months after PRK-CXL, the mean decimal UDVA improved significantly from 0.20 ¡À 0.12 (SD) to 0.55 ¡À 0.15 (P<.01). The mean decimal CDVA improved from 0.58 ¡À 0.13 to 0.77 ¡À 0.17 (P=.01). The mean cylinder decreased from ?3.60 ¡À 1.70 to ?1.30 ¡À 1.10 diopters (D) (P<.001). The mean apex K decreased from 50.91 ¡À 5.50 D to 46.61 ¡À 4.52?D (P<.005). The other corneal parameters did not change significantly after treatment. No significant difference was found between the 6-month and 12-month results. No patient lost lines of CDVA. Mild haze remained in 11.1 % of eyes 12 months after treatment.

Conclusions

Simultaneous wavefront-guided PRK and CXL for keratoconus after ICRS implantation was safe and effective. It significantly improved the UDVA, CDVA, and central K?value, and consequently the visual function, of patients with moderate keratoconus.

Financial Disclosure

No author has a financial or proprietary interest in any material or method mentioned.